IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,814 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,675,000 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,052,000 | $11,459,000 | 0.69% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 14,416,000 | $15,218,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,767,000 | $29,301,000 | 0.29% |
| AQR Arbitrage LLC | 5,200,000 | $5,486,000 | 0.12% |
| CSS LLC/IL | 2,500,000 | $2,635,000 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,700,000 | $18,674,000 | 0.09% |
| Jefferies Group LLC | 10,096,000 | $10,674,524 | 0.09% |
| Daiwa Securities Group Inc. | 5,000,000 | $5,261,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,910,000 | 0.03% |